(DON) WisdomTree U.S. MidCap - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US97717W5058
DON: ETF, Mid-Cap, Dividend, Investments
The WisdomTree U.S. MidCap Dividend Fund (DON) is an exchange-traded fund (ETF) that primarily invests in mid-cap U.S. companies with a history of paying dividends. The fund tracks a fundamentally weighted index, meaning that the constituent securities are weighted based on their dividend yield, rather than market capitalization.
The funds investment strategy is focused on the mid-capitalization segment of the U.S. dividend-paying market, which may include companies that are not necessarily large-cap or growth-oriented. This approach may provide a more stable source of returns, as dividend-paying companies tend to be less volatile than non-dividend payers. With a non-diversified portfolio, DON may be more susceptible to stock-specific risks, but it also allows for more concentrated positions in the funds highest-conviction holdings.
Analyzing the funds technical data, we can see that the current price is $49.62, slightly above its 20-day simple moving average (SMA) of $49.34. The 50-day SMA is $47.88, indicating a longer-term uptrend. However, the 200-day SMA is $50.08, which may act as a resistance level. Given the current ATR of 0.69 (1.39%), the funds price is experiencing moderate volatility.
Using historical data and fundamental analysis, we can forecast that DON may continue to benefit from its focus on dividend-paying mid-cap stocks. With an AUM of $3.6 billion, the fund has a stable asset base, which can help to reduce trading costs and improve liquidity. Assuming a stable interest rate environment and a continued appetite for dividend-paying stocks, we forecast that DONs price may appreciate to $52.50 over the next 6-12 months, representing a potential upside of 5.8% from current levels.
This forecast is based on a combination of technical and fundamental factors, including the funds trend and momentum indicators, as well as its underlying investment strategy and market positioning. As with any investment, there are risks and uncertainties that may impact the funds performance, and actual results may differ from our forecast.
Additional Sources for DON ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
DON ETF Overview
Market Cap in USD | 3,597m |
Category | Mid-Cap Value |
TER | 0.38% |
IPO / Inception | 2006-06-16 |
DON ETF Ratings
Growth Rating | 67.2 |
Fundamental | - |
Dividend Rating | 48.1 |
Rel. Strength | -4.42 |
Analysts | - |
Fair Price Momentum | 49.53 USD |
Fair Price DCF | - |
DON Dividends
Dividend Yield 12m | 2.07% |
Yield on Cost 5y | 4.27% |
Annual Growth 5y | 3.68% |
Payout Consistency | 95.3% |
Payout Ratio | % |
DON Growth Ratios
Growth Correlation 3m | 43.8% |
Growth Correlation 12m | 11.1% |
Growth Correlation 5y | 87.4% |
CAGR 5y | 15.72% |
CAGR/Max DD 5y | 0.73 |
Sharpe Ratio 12m | -0.08 |
Alpha | -3.35 |
Beta | 0.817 |
Volatility | 16.71% |
Current Volume | 92.6k |
Average Volume 20d | 114.4k |
As of June 25, 2025, the stock is trading at USD 50.05 with a total of 92,584 shares traded.
Over the past week, the price has changed by +2.23%, over one month by +1.13%, over three months by +0.39% and over the past year by +8.19%.
Yes. Based on ValueRay´s Analyses, WisdomTree U.S. MidCap (NYSE ARCA:DON) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.16 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DON is around 49.53 USD . This means that DON is currently overvalued and has a potential downside of -1.04%.
WisdomTree U.S. MidCap has no consensus analysts rating.
According to our own proprietary Forecast Model, DON WisdomTree U.S. MidCap will be worth about 56.7 in June 2026. The stock is currently trading at 50.05. This means that the stock has a potential upside of +13.25%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 56.7 | 13.2% |